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ABSTRACT 
Dengue virus (DENV) causes the major arboviral disease of the tropics, characterized 
in its severe forms by signs of hemorrhage and plasma leakage. DENV encodes a 
nonstructural glycoprotein NS1 that associates with intracellular membranes and the 
cell surface. NS1 is eventually secreted as a soluble hexamer from DENV-infected 
cells and circulates in the bloodstream of infected patients. Extracellular NS1 has been 
shown to modulate the complement system and to enhance DENV infection, yet its 
structure and function remain essentially unknown. By combining cryo-electron 
microscopy analysis with a characterization of NS1 amphipathic properties, we show 
that the secreted NS1 hexamer forms a lipoprotein particle with an open-barrel protein 
shell and a prominent central channel rich in lipids. Biochemical and NMR analyses of 
the NS1 lipid cargo reveals the presence of triglycerides, bound at an equimolar ratio to 
the NS1 protomer, as well as cholesteryl esters and phospholipids, a composition 
evocative of plasma lipoproteins involved in vascular homeostasis. This study suggests 
that DENV NS1, by mimicking or hijacking lipid metabolic pathways, contributes to 
endothelium dysfunction, a key feature of severe dengue disease. 
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INTRODUCTION  
DENV (genus Flavivirus, family Flaviviridae) is responsible for the major arthropod-
borne viral human disease of the tropics (1). It is estimated that 50-100 million dengue 
cases occur annually, ranging from mild fever to life-threatening dengue hemorrhagic 
fever (DHF) and dengue shock syndrome (DSS) (2). The number of severe forms can 
exceed half a million per year, and lead to tens of thousand deaths (1). DHF is 
associated to thrombocytopenia, coagulopathy, acute inflammation, frequent 
hepatomegaly, and most importantly, plasma leakage to which the risk of fatal 
hypovolemic shock (DSS) is associated (3-5). It has been proposed that an inadequate 
immune response is the major cause of severe clinical manifestations (6-8). Soluble 
mediators produced during the acute phase of the disease likely play a pivotal role in 
vascular permeability, as suggested by the rapid recovery of most DHF patients (9-11). 
There is accumulating evidence that flavivirus NS1, a ~50 kDa nonstructural 
glycoprotein, participates to different stages of the virus life cycle. Part of NS1 resides 
in virally-induced intracellular organelles where it plays an essential role in viral 
replication (12-16). The protein, possibly modified by glycosylphosphatidylinositol 
(GPI), also associates to lipid rafts at the plasma membrane and mediates a signaling 
pattern common to GPI-anchored proteins in the presence of specific antibodies (17-
19). NS1 is eventually secreted by DENV-infected mammalian cells (20-22) and 
released in the blood stream of infected individuals (23, 24). The protein is detectable 
in plasma from the onset of fever up to the first days of convalescence, at 
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concentrations that can exceed several µg/mL (23-25). The amount of NS1 circulating 
in human sera appears significantly higher in patients who developed DHF rather than 
dengue fever (26), although it is not clear whether this effect is a cause or a 
consequence of plasma leakage. In vitro, the protein binds cell surface 
glycosaminoglycans (27) and is targeted to late endosomes upon entry into target cells 
(28). Pre-incubation of hepatocytes with soluble NS1 enhances subsequent infection by 
a homologous strain of DENV (28). In addition, both soluble and cell-surface-
associated NS1 are capable of modulating complement activation pathways through the 
formation of immune complexes or binding to host proteins such as the regulatory 
protein factor H, complement factor C4 or clusterin (29-32). 
In this paper, we investigated the structure/function relationship of DENV NS1. 
We determined a low-resolution three-dimensional reconstruction of the hexamer, 
which appears as an open barrel with a wide central channel. We identified that 
specific lipids associate to the NS1 particle, in particular triglycerides, cholesteryl 
esters and phospholipids that likely fit into the central cavity. These results point to 
striking similarities between DENV NS1 and high density lipoproteins (HDL) involved 
in vascular homeostasis. 
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RESULTS 
Three-dimensional (3D) organization of the DENV NS1 hexamer 
To get insights into the NS1 structure/function relationship, we sought to 
characterize the 3D organization of the secreted hexamer. We analyzed an authentic 
NS1 protein purified from the extracellular medium of Vero cells infected with DENV 
serotype 1 (DENV-1). Numerous crystallization trials failed to yield diffraction quality 
crystals. Using cryo-electron microscopy (cryo-EM), we obtained a 3D reconstruction 
of the DENV-1 NS1 hexamer. The resolution of the reconstruction (at about 3.0 nm) 
allows to visualize the protein as an open barrel with a 32 point-symmetry, 
approximately 10 nm in diameter and 9 nm in height, featuring a prominent central 
channel running along the molecular 3-fold axis (Fig. 1). Three 2-fold symmetric 
twisted rods, corresponding to the dimeric subunits, form the walls lining the channel. 
The lateral interactions between the dimeric building blocks take place along a fairly 
thin area representing at most 5 nm2. Each rod is made of two ellipsoidal lobes, which 
most likely correspond to the individual protomers (Fig. 1 and Fig. S2). The central 
channel has an estimated volume of 80 nm3 with triangular openings of about 9 nm2 at 
each end, rotated by 40 degrees about the 3-fold axis (Fig. 1C).  
 
The DENV NS1 dimeric subunits behave as membranous proteins in a Triton X-
114 detergent phase partitioning assay. 
The very narrow interfaces observed between the dimeric subunits, together with 
the previously reported instability of the NS1 hexamer in nonionic detergents (20, 33) 
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and its resistance to high molarities of salt or to chelating agents (Fig. S3), indicated 
that the dimers are essentially held together by weak hydrophobic interactions. Further 
elements localizing within the channel are likely to be necessary to hold the dimeric 
rods together, for instance amphiphilic molecules such as lipids, as inferred by the dual 
behavior of the protein in a TX-114 detergent phase partitioning assay (Fig. 2). 
Whereas soluble and membranous proteins segregate in the aqueous and detergent 
phases, respectively, the detergent-treated NS1 partitions into both phases, with a 
higher proportion of protein retained in the detergent fraction (Fig. 2A). The DENV E 
protein, which contains a transmembrane anchor, remains exclusively in the detergent 
phase, as expected (Fig. 2A). NS1 recovered from the detergent-rich phase is 
essentially dimeric, as observed by treatment of the corresponding fraction with 
chemical cross-linker dimethylsuberimidate (DMS) and analysis of the resulting 
products by SDS/PAGE and Coomassie blue staining or mass spectrometry (Fig. 2B 
and 2C, respectively). In contrast, NS1 from the aqueous phase maintains its 
characteristic hexameric pattern with DMS treatment (Fig. 2B, 2C). Thus, the soluble 
hexamer is composed of amphipathic dimeric subunits that behave as membrane 
proteins upon dissociation. This indicates that dimeric precursors likely interact with 
lipid membranes prior to hexamer assembly, possibly dragging lipids out of the 
membrane during the oligomeric transition. 
 
The NS1 protein is secreted as a lipoprotein particle rich in triglycerides. 
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To investigate the presence of lipids in the DENV NS1 particle, we subjected 
NS1 to treatment with organic solvent and separated the lipid moiety on thin layer 
chromatography (TLC). A predominant species, well resolved on the TLC plate 
(Fig. 3A, arrow), was recovered and analyzed by nuclear magnetic resonance (NMR, 
Fig. 3B). The 1H NMR spectrum displays the characteristic signals of triglycerides 
(TG), including peaks at 5.17, 4.17 and 4.03 ppm related to protons of the glycerol 
moiety, and the corresponding cross peaks in 2D double quantum filtered correlation 
spectroscopy (DQF-COSY) (Fig. 3B). This was corroborated by gaz-liquid 
chromatography (GLC) analysis of NS1-associated TG (Fig. 3C). TG molecules are 
formed by three fatty acid chains that can all be different or all alike. Their length and 
degree of saturation is variable, although aliphatic chains with 16, 18 and 20 carbon 
atoms, which may contain one or two double bonds, are most frequently observed. 
GLC analysis of fatty acids derived from DENV-1 NS1 TG shows two major peaks 
corresponding to saturated palmitic acid (16:0) and unsaturated oleic acid (18:1), as 
well as minor polyunsaturated palmitoleic acid (16:1) and linoleic acid (18:2), and 
other peaks that likely correspond to background signals (Fig. 3C). Compared to 
authentic NS1 recovered from the supernatant of DENV-1 infected Vero cells, 
recombinant DENV-2 NS1 produced in Drosophila S2 cells also contains TG that 
display a homogeneous fatty acid profile composed of palmitic acid and stearic acid 
(18:0) (Fig. 3C). TG molecules extracted from control HDL particles are formed by 
palmitic, oleic and linoleic acid (Fig. 3C).  
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The NS1 lipid moiety is similar to the lipid cargo of high density lipoproteins. 
In addition to TG, we were able to isolate cholesteryl ester (CE) molecules from 
the NS1 hexamer of DENV type-1 and -2. Sterol esters were isolated from recombinant 
NS1 preparations, separated on TLC plate and saponified. The corresponding sterol 
fractions were found to be identical to standard cholesterol both by GLC and mass 
spectrometry (Fig. 4). Other lipid species were identified by TLC and GLC, including 
mono- and diacylglycerol, phosphatidylcholine (PC) and phosphatidyl-ethanolamine 
(PE). We estimated the number of lipid molecules by comparing the amount of fatty 
acid chains (fatty acid methyl esters recovered by transesterification of NS1-associated 
lipids) to a defined amount of a C17 standard on GLC. By this method, we found that 
each NS1 hexamer binds 6 TG molecules (i.e. one per protomer), twice as many mono- 
and diacylglycerol molecules, 16-33 CE and 18-27 phospholipids (Table 1). 
Cholesterol and sphingomyelin (SM) were also observed on TLC but not quantified. 
Overall, the NS1 lipid composition is very similar to that of HDL, although HDL show 
a higher lipid:protein weight ratio (Table 1). Accordingly, the NS1 hexamer is denser 
than what would be expected for an HDL particle of similar size (1.20-1.23 g/mL for 
the NS1 hexamer in comparison to 1.063-1.12 g/mL for 9-12 nm wide HDL) and rather 
fits within the class of very high density lipoproteins (VHDL, 1.21-1.25 g/mL), close to 
soluble proteins (1.26-1.28 g/mL). Of note, we found that the hexameric organization 
and lipid content is identical for two different DENV serotypes of the NS1 protein 
(Table 1 and Fig. 3C). 
 
 10
Modeling lipid organization within the DENV NS1 channel. 
We calculated that about 70 lipid molecules could be extracted from a single 
NS1 hexamer particle, representing a total volume of roughly 75 nm3 based on the 
specific volumes of the various lipid species (34, 35). These numbers do not take into 
account molecules of cholesterol and SM that are part of the lipid cargo. Depending on 
the lipid composition, and the presence of cholesterol in particular (35), lipid 
compaction events can occur, suggesting that the whole NS1 lipid cargo can fit well 
into the 80 nm3 channel. TG and CE probably constitute the central lipid core while 
charged lipids such as PC, PE and SM rather occupy the outer layers, at either end of 
the NS1 channel. As described above, we estimate that there are between 18-27 
phospholipids in total (i.e. 9-13 per channel opening). Considering an average surface 
area of 0.5 nm2 per phospholipid (34, 35), these can fill about 60% of the 9 nm2 
triangular surface present at each end of the NS1 channel (Fig. 1), leaving extra space 
for other polar lipids, such as sphingolipids and glycolipids. Altogether, the amount of 
lipids extracted from the NS1 particle is compatible with the dimensions of the central 
channel.  
 11
DISCUSSION 
The flavivirus nonstructural protein NS1 has long been reported to undergo a 
complex maturation process. On the one hand, it is attached to intracellular membranes 
and the surface of infected cells, on the other, it is secreted in the extracellular medium 
and circulates in the serum of infected patients. In this study, we used a combination of 
biochemical and structural approaches to investigate the organization and composition 
of NS1 released by DENV-infected cells.  
We obtained a cryo-electron microscopy reconstruction of the secreted form of 
NS1, which reveals a barrel-like hexameric particle of about 10 nm in diameter, in 
which the three dimeric rods interact along narrow lateral surfaces and form a wide 
central channel (Fig. 1). The channel was a most unexpected finding and we 
investigated its possible contribution to NS1 structure/function. As the contact areas 
between the dimers appeared insufficient to maintain the hexameric state of NS1 in 
solution (36), and were not consistent with the high stability of the protein in an 
aqueous environment, we searched for the presence of stabilizing elements that would 
localize within the channel. The dual behavior of the NS1 protein in a TX-114 
detergent phase partitioning assay, in which the dimeric subunits partition to the 
detergent phase just as membrane proteins while the NS1 hexamer remains in the 
aqueous phase, indicated that amphiphilic molecules such as lipids could possibly be 
present (Fig. 2). Lipids could indeed be isolated from purified hexamer preparations 
and we observed a heterogenous population by TLC with one predominant species 
identified by NMR as TG (Fig. 3). Other NS1-associated lipid species included mono- 
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and diacylglycerol, cholesterol, CE, PC, PE and SM, an overall lipid composition thus 
very close to that of endogenous HDL circulating in plasma. 
Despite the notable homology of their lipid content, DENV NS1 and HDL 
particles have a fundamentally different protein organization. While HDL particles are 
composed of narrow ribbons of apolipoprotein A1 that tie up a large lipid bundle (37-
39), the NS1 hexamer consists of a thick protein shell organized as an open barrel that 
can only accommodate a much smaller lipid cargo compared to HDL of similar size. 
Accordingly, the density of the NS1 hexamer (1.20-1.23 g/mL) rather corresponds to 
the smallest subclass of HDL particles (i.e., less than 7 nm in diameter). We estimate 
that over 70 lipid molecules associate to an NS1 hexamer, which is in agreement with 
the amount of lipids that could theoretically fit into the central channel (35). According 
to a model of lipid distribution in lipoprotein particles (34), we hypothesize that TG, 
along with CE, preferentially constitute the central core of the lipid cargo, around 
which polar lipids (PC, PE, SM in particular) can pack, their charged heads facing the 
aqueous environment at either opening of the NS1 channel.  
The mechanism by which NS1 acquires its lipid cargo appears to involve an 
initial interaction of NS1 dimers with intracellular membranes. Since recombinant 
NS1, lacking the putative glycosylphosphatidylinositol (GPI)-anchor signal present in 
the downstream NS2A coding region (17, 19), shows no difference in lipid binding 
capacity in comparison to native NS1, a GPI modification cannot account for NS1 
attachment to membranes. Early studies following the folding process of NS1 in the 
endoplasmic reticulum (ER) indicated that the NS1 monomer is water-soluble and 
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becomes membrane-associated once the protein dimerizes (40). We propose that lipid-
binding sites form during the dimerization process itself, possibly at the dimer interface 
(i.e. between the two lobes of the dimer, Fig. 1). The 1:1 molar ratio of TG to NS1 (i.e., 
six TG molecules per NS1 hexamer, Table 1) suggests that NS1 dimers would bind 
specifically the hydrophilic head of the lipid. As intracellular TG essentially 
accumulates between the two leaflets of the ER membrane, from which cytosolic lipid 
droplets (LD) arise (41, 42), one possibility is that NS1 dimers insert into the hemi-
membrane, thus gaining access to the neutral lipid pool. Such insertion would locally 
destabilize the organization of lipids, favoring the association of three NS1 dimers 
around a lipid cargo and its release from the membrane by pinching off, as pictured in 
Fig. S1. The association of secreted NS1 with TG links the DENV cycle to the 
biogenesis of LD within the infected cell. This corroborates a recent report indicating 
that the interaction of the DENV capsid (C) protein with LD is essential for viral 
replication and virus particle assembly (43), thus raising the question as to whether C 
and NS1 cooperate in any way to hijack nascent LD and support intracellular viral 
processes.  
The discovery that DENV NS1 carries lipids in the extracellular milieu (Fig. S1) 
also has important pathophysiological implications. Lipoproteins are known to play a 
key role in vascular homeostasis and defects in lipoprotein functions can affect 
coagulation and predispose to vascular inflammation and thrombosis (44, 45). By 
diverting certain lipids from their original fate, NS1 has the potential to interfere with 
the biogenesis of endogenous lipoprotein particles (46) or to deregulate the intracellular 
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lipid sensing machinery during entry into target cells (47, 48). In line with our 
observations, several reports show that DENV-infected patients who developed 
DHF/DSS present a decrease of high- and low-density lipoprotein content in plasma, 
and altered levels of cholesterol and triglycerides (49-51). Moreover, the nutritional 
status of children appears to impact the risk of developing a fatal DHF/DSS (52, 53). 
The NS1 lipoprotein particle can also directly modulate host response by binding to 
factors of the complement system (29, 32), either as part of a viral escape mechanism 
or as a mean to exacerbate inflammation (54, 55). 
In conclusion, our study identifies a novel class of lipoprotein particle, 
exemplified by the barrel-like DENV NS1 protein. The organization of the NS1 
hexamer around a “soft” lipid core explains at least in part the lack of success in the 
crystallization efforts and the limited resolution of the cryo-EM reconstruction. The 
striking similarities of the NS1 lipid moiety with that of HDL suggests that NS1 has the 
potential of interfering with the vascular system and inducing important physiological 
disorders during its circulation in infected patients. The NS1 properties reported here 
are common to different DENV serotypes, opening promising new therapeutic avenues 
to fight dengue disease, such as interfering with NS1 secretion or targeting its 
hydrophobic channel. 
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EXPERIMENTAL PROCEDURES 
 
Three-dimensional reconstruction of the DENV NS1 hexamer. Cryo-electron 
microscopy analysis of the NS1 protein sample was carried out with a Philips CM12 
transmission electron microscope using a LaB6 filament at 120 kV. Images were 
analyzed with EMAN and EM software packages. Characteristic class averages 
representing different orientations of the particles on the micrograph were used to 
calculate an initial 3D reconstruction, which was further refined, as described in the 
Supporting Information section, to obtain a final electron density map to a resolution of 
about 3 nm. 
 
Triton X-114 detergent phase partitioning assay. Triton X-114 detergent phase 
partitioning was performed on purified preparations of NS1 using a pre-condensed 
preparation of Triton X-114 at a 1% final concentration. Following an overnight 
incubation at 4°C, potential aggregates were pelleted by high speed centrifugation 
(insoluble fraction) before separating the detergent from the aqueous phase at 30°C. In 
a set of experiments, proteins from the aqueous and detergent phases were further 
cross-linked with dimethylsuberimidate (DMS) at 4°C. Proteins were analyzed by 
SDS-PAGE and Coomassie Blue staining or by mass spectrometry on a PBS II mass 
reader (Ciphergen Biosystems, Inc.). The DENV envelope protein E was used a control 
transmembrane protein and detected by Western Blotting. 
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Characterization of the NS1 lipid moiety. Potential lipid components were extracted 
using a standard solvent extraction procedure. Lipid were analyzed by TLC and stained 
with iodine or dichlorofluoresceine. Different lipid classes were trans-esterified for 
their characterization by GLC. Fatty acid methyl esters (FAMEs) were analyzed on an 
Agilent Technologies chromatograph model 6890 equipped with a BPX 70 fused silica 
capillary column (60mx 0.25mm i.d., 0.25 µm film thickness). One of the predominant 
lipid species was also subjected to NMR (see Supplemental Methods). The NMR 
spectra were acquired on a Bruker 600MHz spectrometer equipped with a triple 
resonance z-axis gradient cryoprobe at 298K, in CDCl3. 
 
Full experimental procedures and associated references are available as Supporting 
Information. 
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FIGURE LEGENDS 
 
Fig. 1. Cryo-EM analysis of DENV-1 secreted NS1. (A) Representative field 
showing a preparation of NS1 purified from DENV-1-infected Vero cell supernatants. 
(B) Characteristic class averages of NS1 used to produce an initial 3D reconstruction. 
(C) 3D reconstruction of NS1, in an isosurface representation. The upper left panel 
displays a view down the 3-fold molecular axis. The lower-left panel is a view down 
the 2-fold axis relating two dimeric subunits (90 degrees rotation as indicated). The 
lower-right panel shows the NS1 particle further rotated by 180 degrees about the 3-
fold axis, down the 2-fold axis relating protomers within a dimeric subunit. The 
intradimer contacts are much more extensive than the interdimer ones. Note the large 
central channel of roughly 80 nm3 running along the 3-fold axis of the molecule.  
 
Fig. 2. The NS1 hexamer is composed of amphipathic dimeric subunits. 
(A) Purified DENV-1 NS1 was treated with the nonionic detergent TX-114 at a 1% 
final concentration (Tot). Aggregated or insoluble material was pelleted in the cold at 
high-speed centrifugation (Ins) before separating the aqueous (Aq) and detergent (Det) 
phases. Proteins from the two phases were analyzed by SDS-PAGE and Coomassie 
blue staining (left panel). The transmembrane DENV-1 envelope protein E, used as a 
control, was detected by immunoblotting (right panel). (B-C) Oligomeric state of TX-
114 partitioned NS1. The protein present in the initial preparation (Tot) and the two 
phases (Aq and Det) was chemically cross-linked with DMS as described in 
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Supplementary Methods and analyzed by (B) SDS-PAGE and Coomassie blue staining 
or (C) SELDI-TOF mass-spectrometry. The stars indicate irrelevant peaks 
corresponding to double-charged species (2H). 
 
 Fig. 3. The NS1 hexamer carries a lipid cargo rich in triglycerides. (A) Thin layer 
chromatography of extracted lipids colored by iodine vapor. Lane 1: PC (flash) and PE 
(rhodamine-labeled, pink) used as markers, Lane 2: lipids associated to DENV-1 NS1. 
One predominantly represented lipid species (arrow) was extracted for further analysis. 
(B) Identification of triglyceride (TG) by 600 MHz NMR 1D proton and 2D COSY-
DQF spectra. Characteristic NMR signals and the corresponding protons of the TG 
moiety are connected by arrows. The cross-peaks between the glycerol protons signals 
(at 5.17, 4.17 and 4.03ppm) are circled, and the connectivities traced. Vinylic to allylic 
protons correlations are boxed. Aliphatic and methyl protons are found around 1.2 and 
0.8ppm, respectively, as expected. (C) GLC analysis of fatty acid derivatives from 
trans-esterified triglycerides. Triglycerides associated to DENV-1 and DENV-2 rNS1 
are composed of three saturated and unsaturated aliphatic chains of 16 or 18 carbon 
atoms long. HDL is shown as a control. 
 
Fig. 4. Identification of NS1-associated cholesteryl ester by GLC-MS. (A, B) Gas 
chromatogram of silylated sterols. In A, free cholesterol was used as a standard. In B, 
the NS1-related sterol derivatives were obtained from the sterol ester population that 
was eluted from the TLC plate and saponified. The sterol fraction was further separated 
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from fatty acids by TLC, silylated and analyzed by GLC. (C) Identification of the NS1-
related sterol derivative by electron impact mass spectrometry. The table presents the 
retention times (RT) as observed in A and B, as well as the m/z ratios of the 
characteristic ion fragments. The values obtained for the NS1-related sterol derivative 
and cholesterol by GLC-MS analysis are identical, suggesting that the NS1-associated 
sterol ester is essentially cholesteryl ester. 
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Identification           RT (min)        MW (g/mol)      m/z  
Cholesterol standard         23.08              386       353 
      339 
      255 
LipidNS1              22.96             386       353 
      339 
      255 
Retention time (min)        
10  5 15  20  30  25  
22.96  
Retention time (min)        
10  5 15  20  30  25  
23.08  
Table 1: Quantification by gas-liquid chromatography of different lipid species 
associated to the DENV-1 NS1 hexamera,b 
a nmol, relative values using a C17 fatty acid calibration standard 
b lipids recovered from 200 µg purified protein preparations (approximately 4.5 nM of 
the 50 kD NS1 protomer; See Supplemental Material) 
c values reported for two different purified NS1 preparations 
 
 Triglycerides Mono-/Diglycerides Cholesterol Ester Phospholipids 
DENV-1 rNS1c 5.3-4.0 7.9-9.8 11.4-23.3 12.5-19.1 
HDL 21.9 11.8 98 63.4
